Showing 721-730 of 1226 results for "".
- Orasis Pharmaceuticals Closes $13 Million Series B Financinghttps://modernod.com/news/orasis-pharmaceuticals-closes-13-million-series-b-financing/2480119/Privately-held Orasis Pharmaceuticals announced the closing of a $13 million Series B financing to be used to advance Orasis’s lead product candidate, CSF-1, an eye drop being developed for the treatment of presbyopia symptoms, through completion of its phase 2b clinical trial. The proceeds will
- Tear Film Innovations Completes $8.5 Million Series B Fundinghttps://modernod.com/news/tear-film-innovations-completes-8-5-million-series-b-funding/2480145/Tear Film Innovations announced it has completed a $8.5 million Series B Preferred Stock funding round led by Visionary Ventures Fund LP and Bluestem Capital. “This successful funding round completes the capitalization for our growth strategy. We are currently making key hires to meet the
- Ophthalmologist Ashley Brissette, MD, Launches New Eye Area Skincare Line Daily Practicehttps://modernod.com/news/ophthalmologist-ashley-brissette-md-launches-new-eye-area-skincare-line-daily-practice/2480861/Daily Practice, a new eye care line by Ashley Brissette (Dr. B), MD, launched with a product called ‘Eye Revive.’ Having worked as an ophthalmologist for 6 years, New York City-based Dr. B said she recognized a growing trend of eye irritation, sensitivity and
- Cathleen McCabe, MD, Appointed Strategic Medical Advisor at Bausch + Lombhttps://modernod.com/news/cathleen-mccabe-md-appointed-strategic-medical-advisor-at-bausch-lomb/2482507/Bausch + Lomb has appointed Cathleen McCabe, MD, as Strategic Medical Advisor. According to B+L, in this new consultancy role, Dr. McCabe will contribute her expertise to Bausch + Lomb’s product portfolio expansion and collaborate with the research and development team to drive in
- Richard Rosen, MD, Receives Founders Award From ASRShttps://modernod.com/news/richard-rosen-md-receives-founders-award-from-asrs/2482366/The American Society of Retina Specialists (ASRS) is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with
- ArcScan Signs Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technologyhttps://modernod.com/news/arcscan-signs-agreement-for-11-15-million-preferred-series-b-investment-with-shanghai-haohai-biological-technology/2479394/ArcScaan announced the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology that will result in a $11.15 million Preferred Series B investment into ArcScan. Haohai is a leading Chinese ophthalmology and medical aesthetics company headquartered in Shanghai, and is pub
- OcuTerra Raises $35 Million Series B Financinghttps://modernod.com/news/ocuterra-raises-35-million-series-b-financing/2480416/
- Qlaris Bio Completes $24 Million Series B Financing Round to Advance IOP-lowering Drug Candidate for Glaucomahttps://modernod.com/news/qlaris-bio-completes-24-million-series-b-financing-round-to-advance-iop-lowering-drug-candidate-for-glaucoma/2482252/Qlaris Bio announced it has closed a $24 million Series B financing round to support the continued clinical development of QLS‑111, a first-in-class therapeutic being developed to lower IOP by targeting episcleral venous pressure (EVP). Qlaris is currently conducting two US ph
- jCyte Announces Pre-Phase 3 Type B Meeting with FDA; Outlines Plans to Start Pivotal Trial of jCell for RPhttps://modernod.com/news/jcyte-announces-pre-phase-3-type-b-meeting-with-fda-outlines-plans-to-start-pivotal-trial-of-jcell-for-rp/2482126/jCyte announced the successful outcome of its pre-phase 3 Type B meeting with the FDA held on January 16, 2024. Additionally, the company is gearing up to commence its pivotal US trial for jCell for retinitis pigmentosa (RP) in the second half of 2024. John Sholar, Chief Executive
- Julie Schornack, OD, Named First Female President of Marshall B. Ketchum Universityhttps://modernod.com/news/julie-schornack-od-named-first-female-president-of-marshall-b-ketchum-university/2481585/Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California has introduced Julie A. Schornack, OD, MEd, as its next president to lead the university. Dr. Schornack is the first female p